Evidence map›Paper›PMID 21200071›Full record

SynthesisThe British journal of psychiatry : the journal of mental science2011

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.

Corrado Barbui, Andrea Cipriani, Vikram Patel, José L Ayuso-Mateos, Mark van Ommeren

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The British journal of psychiatry : the journal of mental science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 8 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 8 syntheses or guidelines pooled it, 220 citations in OpenAlex.

  1. Pooled it
  2. Antidepressants for the treatment of depression in people with cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Industry sponsorship and research outcome.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Antidepressants for the treatment of depression in people with cancer.The Cochrane database of systematic reviews · 2015
    Pooled it
  5. Psychotherapy for subclinical depression: meta-analysis.The British journal of psychiatry : the journal of mental science · 2014
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 5 countries.

Corrado BarbuiDepartment of Public Health and Community Medicine, Section of Psychiatry and Clinical Psychology, University of Verona, Policlinico GB Rossi, 37134 Verona, Italy. corrado.barbui@univr.it
Andrea Cipriani
Vikram Patel
José L Ayuso-Mateos
Mark van Ommeren
University of Verona · ITCentro de Investigación Biomédica en Red de Salud Mental · ESSangath · INWorld Health Organization · CH

Funding

Wellcome Trust 091834
6 · The paper itself

Abstract

backgroundDepression is a common condition that has been frequently treated with psychotropics.

aimsTo review systematically the evidence of efficacy and acceptability of antidepressant and benzodiazepine treatments for patients with minor depression.

methodA systematic review and meta-analysis of double-blind randomised controlled trials comparing antidepressants or benzodiazepines v. placebo in adults with minor depression. Data were obtained from MEDLINE, CINAHL, EMBASE, PsycInfo, Cochrane Controlled Trials Register and pharmaceutical company websites. Risk of bias was assessed for the generation of the allocation sequence, allocation concealment, masking, incomplete outcome data, and sponsorship bias.

resultsSix studies met inclusion criteria. Three studies compared paroxetine with placebo; fluoxetine, amitriptyline and isocarboxazid were studied in one study each. No studies compared benzodiazepines with placebo. In terms of failures to respond to treatment (6 studies, 234 patients treated with antidepressants and 234 with placebo) no significant difference between antidepressants and placebo was found (relative risk (RR) 0.94, 95% CI 0.81-1.08). In terms of acceptability, data extracted from two studies (93 patients treated with antidepressants and 93 with placebo) showed no statistically significant difference between antidepressants and placebo (RR=1.06, 95% CI 0.65-1.73). There was no statistically significant between-study heterogeneity for any of the reported analyses.

conclusionsThere is evidence showing there is unlikely to be a clinically important advantage for antidepressants over placebo in individuals with minor depression. For benzodiazepines, no evidence is available, and thus it is not possible to determine their potential therapeutic role in this condition.

Indexed as

AdolescentAdultAntidepressive AgentsBenzodiazepinesData Interpretation, StatisticalDepressionDouble-Blind MethodFemaleHumansMaleOutcome Assessment, Health CarePlacebosRandomized Controlled Trials as TopicAntidepressive AgentsBenzodiazepinesPlacebos

Identifiers

PMID21200071
PMCPMC3014462
OpenAlexW2102151931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.